Filed before 2025Filed 29 December 2023
InSitu Biologics, Inc raised $3M
InSitu Biologics, Inc, a biotech company based in Oakdale, MN, raised $3M in a new debt round, according to a filing dated 29 December 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 29 December 2023
- Round
- Debt round
- Amount sold
- $3M
- Offering size
- $3M
- Investors so far
- 1
- Based in
- Oakdale, MN
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 29% of the 1,396 tracked raises with an amount filed in 2023, and than 27% of the 142 in biotech.
InSitu Biologics, Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 10 Aug 2026 | New filing | $1.25M | Not tracked |
| 18 Dec 2025 | New filing | $3.95M | Not tracked |
| 29 Dec 2023 | New filing | $3M | This raise |
| 25 Feb 2021 | New filing | $4.97M | Another raise |
More with SightLine Optics on the board
- Preceptis Medical, Inc.$2.56M
- Aria CV, Inc.$1.38M
- Conformal Medical, Inc.$31.8M
- Rivermark Medical, Inc.$4.12M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.